Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/01/2012
PIL Orgalutran 0.25 mg/0.5 ml solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Extra statutory information
Updated on 17/10/2011 and displayed until 13/01/2012
Reasons for adding or updating:
  • Change to Further Information section
Updated on 24/02/2011 and displayed until 17/10/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 28/05/2010 and displayed until 24/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
Updated on 13/05/2010 and displayed until 28/05/2010
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 21/07/2008 and displayed until 13/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 15/11/2007 and displayed until 21/07/2008
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
  • Change to how to administer the medicine
  • Change to date of revision
Updated on 14/02/2006 and displayed until 15/11/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 28/10/2005 and displayed until 14/02/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 14/12/2004 and displayed until 28/10/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  ganirelix